Literature DB >> 21442159

Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?

M P Schlaich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21442159     DOI： 10.1007/s00125-011-2121-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  Time of exposure and type of diabetes may determine treatment outcome of group clinics.

Authors:  Massimo Porta; Marina Trento
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

Review 2.  Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

Authors:  Albert Quan
Journal:  Early Hum Dev       Date:  2006-01-19       Impact factor: 2.079

3.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

Review 4.  Update on the use of antihypertensive drugs in pregnancy.

Authors:  Tiina Podymow; Phyllis August
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

5.  Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.

Authors:  Murray Esler; Elisabeth Lambert; Markus Schlaich
Journal:  J Appl Physiol (1985)       Date:  2010-02-25

6.  Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies.

Authors:  Vellore J Karthikeyan; Robin E Ferner; Sabah Baghdadi; Deirdre A Lane; Gregory Y H Lip; D Gareth Beevers
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

7.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

8.  Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?

Authors:  Lene Ringholm Nielsen; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

9.  Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.

Authors:  Alissa R Caton; Erin M Bell; Charlotte M Druschel; Martha M Werler; Angela E Lin; Marilyn L Browne; Louise-Anne McNutt; Paul A Romitti; Allen A Mitchell; Richard S Olney; Adolfo Correa
Journal:  Hypertension       Date:  2009-05-11       Impact factor: 10.190

10.  RETIRED: Teratogenicity associated with pre-existing and gestational diabetes.

Authors:  Victoria M Allen; B Anthony Armson
Journal:  J Obstet Gynaecol Can       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.